|
COPYRIGHT 2005 International Medical News Group
KEY BISCAYNE, FLA. -- Sentinel lymph node biopsy confers a survival benefit in patients who have primary cutaneous melanoma, according to preliminary results of a 5-year study.
"We're thrilled to see these data support not only sentinel lymph node biopsy for staging, but [also] that it offers a survival advantage," Neil Alan Fenske, M.D., said. The results are not yet published, but Dr. Fenske provided a sneak preview of them at the annual meeting of the Noah Worcester Dermatological Society....
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
